Physiologic Factors Contributing to a Transition in Oral Immunity among Mechanically Ventilated Adults

Biological Research For Nursing

Volumn 3, Issue 3, 2002, Pages 132-139

  O’neal, Pamela V ^a   Brown, Nicole ^b   Munro, Cindy ^b  

^a GORDON COLLEGE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

immune system; mechanical ventilation; nosocomial pneumonia; oral immunity; oral secretions; Ventilator associated pneumonia

Indexed keywords

ADULT; ARTIFICIAL VENTILATION; BACTERIUM ADHERENCE; CROSS INFECTION; HUMAN; IMMUNITY; IMMUNOLOGY; MICROBIOLOGY; MOUTH; PNEUMONIA; REVIEW;

ADULT; BACTERIAL ADHESION; CROSS INFECTION; HUMANS; IMMUNITY; MOUTH; PNEUMONIA; RESPIRATION, ARTIFICIAL;

EID: 0036358912     PISSN: 10998004     EISSN: None     Source Type: Journal    
DOI: 10.1177/1099800402003003003     Document Type: Article

References (53)

1. Abele-Horn M, Dauber A, Bauernfeind A, Russwurm W, Seyfarth-Metzger I, Gleich P, Ruckdeschel G. 1997. Decrease in nosocomial pneumonia in ventilated subjects by selective oropharyngeal decontamination (SOD). Intensive Care Med 23: 187-195.
2. Atkinson JC, Yeh C, Oppenheim FG, Bermudez D, Baum BJ, Fox PC. 1990. Elevation of salivary antimicrobial proteins following HIV-1 infection. J Acquir Immune Defic Syndr 3: 41-48.
3. Bannister BA, Begg NT, Gillespie SH. 1996. Infectious disease. Oxford: Blackwell Science.
4. Boackle RJ. 1991. The interaction of salivary secretions with the human complement system—a model for the study of host defense systems on inflamed mucosal surfaces. Crit Rev Oral Biol Med 2: 355-367.
5. Bonten MJ, Froon AH, Gaillard CA, Greve JW, de Leeuw PW, Drent M, Stobberingh EE, Burman WA. 1997. The systemic inflammatory response in the development of ventilatorassociated pneumonia. Am J Respir Crit Care Med 156: 1105-1113.
6. Casey LC, Balk RA, Bone RC. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119: 771-778.
7. Chandler DC, Silverman MS, Lundblad RL, McFall WT. 1974. Human parotid IgA and periodontal disease. Arch Oral Biol 105: 228-233.
8. Chollet-Martin S, Montravers P, Gibert C, Elbim C, Desmonts JM, Fagon JY, Gougerot-Pacidalo MA. 1993. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun 61: 4553-4559.
9. Coogan MM, Sweet SP, Challacombe SJ. 1994. Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect Immun 62: 892-896.
10. Craven DE, Barber TW, Steger KA, Montecalvo MA. 1990. Nosocomial pneumonia in the 1990s: update of epidemiology and risk factors. Semin Respir Infect 5: 157-172.
11. Craven DE, Driks MR. 1987. Nosocomial pneumonia in the intubated patient. Semin Respir Infect 2: 20-33.
12. Craven DE, Steger KA, Barber TW. 1991. Preventing nosocomial pneumonia: state of the art and perspectives for the 1990s. Am J Med 91: 44S-53S.
13. Cuida M, Hasle AK, Johannessen AC, Tynning T, Jonsson R. 1997. Indicators of salivary gland inflammation in primary Sjogren's syndrome. Eur J Oral Sci 105: 228-233.
14. Estes RJ, Meduri GU. 1995. The pathogenesis of ventilator-associated pneumonia: I. Mechanisms of bacterial transcolonization and airway inoculation. Intensive Care Med 21: 365-383.
15. Evans MR, Wansbrough-Jones MH. 1996. Alveolar macrophage activation in HIV infection. J Infect 33: 91-94.
16. Fagon JY, Noara A, Stephan F, Girou E, Safar M. 1994. Mortality attributable to nosocomial infections in the ICU. Infect Control Hosp Epidemiol 15: 428-434.
17. Grap MJ, Munro C. 1997. Ventilator associated pneumonia: clinical significance and implications for nursing. Heart Lung 26: 419-429.
18. Greene R, Thompson S, Jantsch HS, Teplick R, Cullen DJ, Greene EM, Whitman G, Hulda C, Llewellyn H. 1994. Detection of pooled secretions above endotracheal-tube cuffs: value of plain radiographs in sheep cadavers and patients. Am J Roentol 163: 1333-1337.
19. Hack CE, De Groot R, Felt-Bersma RJJ, Nuijens JH, Strach Van Schijndel RJ, Erenberg-Belmer AJ, Thijs LG, Arden LA. 1989. Increased plasma levels of interleukin-6 in sepsis. Blood 74: 1704-1710.
20. Hack CE, Hart M, Strack Van Schijndel RJ, Erenberg AJ, Nuijens JH, Thijs LG, Aarden LA. 1992. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 60: 2835-2842.
21. Horan TC, White JW, Jarvis WR, Emori G, Culver D, Munn V, Thornsberry C, Olson D, Hughes J. 1986. Nosocomial infection surveillance, 1984. MMWR Morb Mortal Wkly Rep 35(Suppl 1SS):17SS-29SS.
22. Immanuel C, Sarma GR, Krishnamurthy PV, Ramachandran G, Kumaraswami V. 1992. Salivary coritsol in the assessment of adrenocortical function in patients with pulmonary tuberculos. Indian J Med Res 95: 1-7.
23. Janeway CA, Travers P. 1994. Immunobiology: the immune system in health and disease. New York: Garland.
24. Johanson WG, Pierce AK, Sanford JP, Thomas G. 1972. Nosocomial respiratory infections with gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med 77: 701-706.
25. Johanson WG, Seidenfeld JJ, de los SR, Coalson JJ, Gomez P. 1988. Prevention of nosocomial pneumonia using topical and parenteral antimicrobial agents. Am Rev Resp Dis 137: 265-272.
26. Kaplan MD, Baum BJ. 1993. The functions of saliva. Dysphagia 8: 225-229.
27. Kertzner RM, Goetz R, Todak G, Cooper T, Lin SH, Reddy MM, Novacenki H, Williams JB, Ehrhardt A, Gorman JM. 1993. Cortisol levels, immune status, and mood in homosexual men with and without HIV infection. Am J Psychiatry 150: 1674-1678.
28. Konttinen YT, Kulomaa M, Malmstrom M, Kilpi A, Reitamo S. 1984. Lactoferrin in Sjogren's syndrome. Arthritis Rheum 27: 462-467.
29. Levine SA, Niederman MS. 1991. The impact of tracheal intubation on host defenses and risks for nosocomial pneumonia. Clin Chest Med 12: 523-543.
30. Lipchik RJ, Kuzo RS. 1996. Nosocomial pneumonia. Radiol Clin North Am 34: 47-58.
31. Mandel ID, Barr CE, Turgeon L. 1992. Longitudinal study of parotid saliva in HIV-1 infection. J Oral Pathol Med 21: 209-213.
32. Marsh P, Martin M. 1992. Oral microbiology (3rd ed.). London: Chapman and Hall.
33. Meduri GU. 1990. Ventilator-associated pneumonia in patients with respiratory failure. A diagnostic approach. Chest 97: 1208-1219.
34. Meduri GU, Headley S, Kohler G, Sten F, Tolle E, Umberger R, Leeper K. 1995. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Chest 107: 1062-1073.
35. Miyasaki KT. 1991. The neutrophil: mechanisms of controlling periodontal bacteria. J Periodontol 62: 761-774.
36. Muller F, Holberg PM, Rollag H, Degre M, Brandtzaeg P, Froland SS. 1992. Nonspecific oral immunity in individuals with HIV infection. J Acquir Immune Defic Syndr 5: 46-51.
37. Nahir AM. 1987. Chemical analysis of whole saliva in Sjogren's syndrome. Ann Rheum Dis 46: 654-657.
38. Niederman MS, Craven DE, Fein AM, Schultz DE. 1990. Pneumonia in the critically ill hospitalized patient. J Hosp Infect 97: 170-181.
39. Rostoker G, Terzidis H, Petit-Phar M, Lang P, Weil B. 1990. Mucosal immunity in adult primary glomerlonephritis: I. Evaluation of salivary Ig A subclasses and components. Nephron 54: 42-46.
40. Rudney JD. 1995. Does variability in salivary protein concentrations influence oral microbial ecology and oral health? Crit Rev Oral Biol Med 6(4):343-367.
41. Rudney JD, Krig MA, Neuvar EK. 1993. Longitudinal study of relations between human salivary antimicrobial proteins and measures of dental plaque accumulation and composition. Arch Oral Biol 38: 377-386.
42. Rudney JD, Krig MA, Neuvar EK, Soberay AH, Iverson L. 1991. Antimicrobial proteins in human unstimulated whole saliva in relation to each other, and to measures of health status, dental plaque accumulation and composition. Arch Oral Biol 36: 497-506.
43. Scannapieco FA, Stewart EM, Mylotte JM. 1992. Colonization of dental plaque by respiratory pathogens in medical intensive care patients. Crit Care Med 20: 740-745.
44. Simpson WA, Beachey EH. 1983. Adherence of group A stretptococci to fibronectin on oral epithelial cells. Infect Immun 39: 275-279.
45. Su H, Boackle RJ, 1991. Interaction of the envelope glycoprotein of human immunodeficiency virus with C1q and fibronectin under conditions present in human saliva. Mol Immunol 28: 811-817.
46. Sweet SP. 1995. IgA subclasses in HIV disease: dichotomy between raised levels in serum and decreased secretion rates in saliva. Immunology 86: 556-559.
47. Tablan OC, Anderson LJ, Arden NH, Breiman RF, Butler JC, McNeil MM. 1994. Guideline for prevention of nosocomial pneumonia. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 22: 247-292.
48. Tishler M, Yaron I, Shirazi I, Yaron M. 1997. Saliva: an additional diagnostic tool in Sjogren's syndrome. Semin Arthritis Rheum 27: 173-179.
49. Torres A, el-Ebiary M, Gonzalez J, Ferrer M, Puig de la Bellacasa J, Gene A, Martos A, Rodriguez-Roisin R. 1993. Gastric and pharyngeal flora in nosocomial pneumonia acquired during mechanical ventilation. Am Rev Respir Dis 148: 352-357.
50. Treloar DM, Stechmiller JK. 1995. Use of a clinical assessment tool for orally intubated patients. Am J Crit Care 4(5):355-360.
51. Vickerman MM, Clewell DB, Jones GW. 1991. Sucrose-promoting accumulation of growing glucosyltransferase variants of Streptococcus gordonii on hydroxyapatite surfaces. Infect Immun 59(10):3523-3530.
52. Vickerman MM, Jones GW. 1995. Sucrose-dependent accumulation of oral streptococci and their adhesion-defective mutants on saliva-coated hydroxyapatite. Oral Microbiol Immunol 10(3):175-182.
53. Vrecko K. 1997. Periodontitis and concentrations of the cellular immune activation marker neopterin in saliva and urine. Clin Chim Acta 268: 31-40.